Company Filing History:
Years Active: 2019
Title: The Innovations of Kelly Zalocusky
Introduction
Kelly Zalocusky is an accomplished inventor based in Mountain View, CA. She has made significant contributions to the field of molecular biology, particularly in the area of dopamine receptor research. Her innovative work has led to the development of a unique nucleic acid that has potential applications in various scientific fields.
Latest Patents
Zalocusky holds a patent for a "Dopamine receptor type 2 specific promoter and methods of use thereof." This patent describes a nucleic acid containing a dopamine receptor type 2-specific promoter (D2SP). The D2SP does not include exon 1 of a D2 receptor gene and comprises a Kozak sequence. The D2SP includes a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 1. Additionally, the patent provides expression vectors, genetically modified host cells, and kits that include the subject nucleic acid. She has 1 patent to her name.
Career Highlights
Zalocusky is affiliated with Leland Stanford Junior University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on understanding dopamine-related functions and disorders.
Collaborations
Throughout her career, Zalocusky has collaborated with notable scientists, including Karl A Deisseroth and Charu Ramakrishnan. These collaborations have further enriched her research and expanded the scope of her innovations.
Conclusion
Kelly Zalocusky's contributions to the field of molecular biology, particularly through her patent on dopamine receptor type 2-specific promoters, highlight her role as a leading inventor. Her work continues to inspire advancements in scientific research and applications.